In the United States, Nearly All Surveyed Physicians Prescribe Pfizer's Sutent ... - MarketWatch (press release) Print
MarketWatch (press release)
The new US Physician & Payer Forum report entitled Advanced Renal Cell Cancer: The Next Wave of Targeted Agents for RCC: Insights from US Payers and Oncologists finds that Sutent is the clear leader in terms of physicians' first-hand experience and

...